Publication

Article

Oncology Live®

June 2011
Volume12
Issue 6

PER Gatherings Focus on Breast, Lung Cancers

Author(s):

Internationally known experts will discuss the latest research in breast and lung cancers at 2 conferences that the Physicians' Education Resource (PER) is hosting in California in August.

Hotel del Coronado

Internationally known experts will discuss the latest research in breast and lung cancers at 2 conferences that the Physicians’ Education Resource (PER) is hosting in California in August.

Joyce O’Shaughnessy, MD, co-director of Breast Cancer Research at the Baylor Charles A. Sammons Cancer Center at Texas Oncology in Dallas, will chair the 10th International Congress on the Future of Breast Cancer from August 4-7 in Coronado. The conference will focus on the clinical implications of breast cancer genetic and phenotypic subtyping, as well as novel agents and strategies.

David Gandara, MD, director of the Thoracic Oncology Program and associate director of Clinical Research at the University of California Davis Cancer Center in Sacramento, and Roy Herbst, MD, PhD, chief of Medical Oncology at the Yale Comprehensive Cancer Center, Smilow Cancer Hospital at Yale-New Haven Yale School of Medicine in Connecticut, will chair the 12th International Lung Cancer Congress from August 11-14 in Carlsbad. An update on research from major Cooperative Groups from the United States, Europe, and Asia will be among the highlights.

Related Videos
Ruth M. O’Regan, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the next steps for biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.